Review decisions
Showing 60 results of 633 total
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1761232014054
Product Type: Drug
Control Number: 287263
Manufacturer: Sanofi Aventis Canada Inc.
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2024-05-29
Decision / Authorization Date: 2025-05-09
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1759845893252
Product Type: Drug
Control Number: 287074
DIN(s): 02471469, 02471477, 02523930, 02540258
Manufacturer: Novo Nordisk Canada Inc.
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2024-05-23
Decision / Authorization Date: 2025-08-13
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1759851654912
Product Type: Drug
Control Number: 286343
DIN(s): 02456869
Manufacturer: Merck Canada Inc.
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2024-04-25
Decision / Authorization Date: 2025-04-11
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1759170708886
Product Type: Drug
Control Number: 286343
Manufacturer: Merck Canada Inc.
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2024-04-25
Decision / Authorization Date: 2025-04-11
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1758815127754
Product Type: Drug
Control Number: 291390
DIN(s): 02445301, 02470640, 02470659, 02470667
Manufacturer: EMD Serono, A Division of EMD Inc., Canada
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2024-10-16
Decision / Authorization Date: 2025-08-11
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1764954565408
Product Type: Drug
Control Number: 289615
DIN(s): 02451816
Manufacturer: Merck Canada Inc.
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2024-08-15
Decision / Authorization Date: 2025-07-31
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1770305064136
Product Type: Drug
Control Number: 278317
DIN(s): 02536455, 02550296, 02561697
Manufacturer: Boehringer Ingelheim (Canada) Ltd.
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2023-08-17
Decision / Authorization Date: 2024-07-31
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1764952797915
Product Type: Drug
Control Number: 293099
DIN(s): 02184435, 02184443, 02184451, 02242163, 02559722
Manufacturer: BGP Pharma ULC
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2024-12-05
Decision / Authorization Date: 2025-07-25
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1759849486740
Product Type: Drug
Control Number: 288802
DIN(s): 02559137, 02559145, 02559153
Manufacturer: Janssen Inc.
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2024-07-22
Decision / Authorization Date: 2025-07-07
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1758129348534
Product Type: Drug
Control Number: 287138
DIN(s): 02498073
Manufacturer: ALK- Abello A/S
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2024-05-24
Decision / Authorization Date: 2025-05-02